Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STIM trial of ovarian stimulation protocols for fertility preservation in women with breast cancer
NL-OMON47167Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tamoxifen, letrozole and follicle-stimulating hormone in breast cancer (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Number of oocytes retrieved. Started Jan 2014; status: active, not recruiting.
02
Drugs
tamoxifenletrozolefollicle-stimulating hormone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON47167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47167.